Blueprint Medicines
(NASDAQ:BPMC)
$94.86
0.07[0.07%]
At close: Mar 28
$94.86
0[0.00%]
After Hours: 4:01PM EDT
37.5%
Overview Rating
Speculative
Technicals Analysis
100
0100

Blueprint Medicines Stock (NASDAQ:BPMC), Quotes and News Summary

Blueprint Medicines Stock (NASDAQ: BPMC) stock price, news, charts, stock research, profile.

Open$95.000
Close$94.860
Volume / Avg.659.240K / 809.341K
Day Range93.500 - 95.980
52 Wk Range41.540 - 101.000
Market Cap$5.808B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
60
Short Interest
11.31%
Days to Cover6.86
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
2
2
Oct 23
3
Dec 23
1
Jan
1
1
1
Feb
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
About Blueprint Medicines Corp
Sector
Health Care
Industry
Biotechnology
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of pat...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
BPMC
IMVT

FAQ

Q

How do I buy Blueprint Medicines (BPMC) stock?

A

You can purchase shares of Blueprint Medicines (NASDAQ: BPMC) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Blueprint Medicines's (BPMC) competitors?

Q

What is the target price for Blueprint Medicines (BPMC) stock?

A

The latest price target for Blueprint Medicines (NASDAQ: BPMC) was reported by Needham on Monday, February 26, 2024. The analyst firm set a price target for 97.00 expecting BPMC to rise to within 12 months (a possible 2.26% upside). 37 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Blueprint Medicines (BPMC)?

A

The stock price for Blueprint Medicines (NASDAQ: BPMC) is $94.86 last updated March 28, 2024 at 4:01 PM EDT.

Q

Does Blueprint Medicines (BPMC) pay a dividend?

A

There are no upcoming dividends for Blueprint Medicines.

Q

When is Blueprint Medicines (NASDAQ:BPMC) reporting earnings?

A

Blueprint Medicines’s Q4 earnings are confirmed for Wednesday, February 15, 2023.

Q

Is Blueprint Medicines (BPMC) going to split?

A

There is no upcoming split for Blueprint Medicines.

Q

What sector and industry does Blueprint Medicines (BPMC) operate in?

A

Blueprint Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch